Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian Green

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
The International Journal of Cardiovascular Imaging|September 22, 2020
Empagliflozin and left ventricular diastolic function following an acute coronary syndrome in patients with type 2 diabetesNick S R Lan, Bu B Yeap, P Gerry Fegan, et al.
Acta Cardiologica|March 8, 2024
Early SGLT2 inhibitor use is associated with improved left atrial strain following acute coronary syndromeAmro Sehly, Albert He, Abdul Rahman Ihdayhid, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
The International Journal of Cardiovascular Imaging|September 22, 2020
Empagliflozin and left ventricular diastolic function following an acute coronary syndrome in patients with type 2 diabetesNick S R Lan, Bu B Yeap, P Gerry Fegan, et al.
Acta Cardiologica|March 8, 2024
Early SGLT2 inhibitor use is associated with improved left atrial strain following acute coronary syndromeAmro Sehly, Albert He, Abdul Rahman Ihdayhid, et al.
Pageof 2